Using AI to De-Risk Rare Disease Drug Development

RARECast - En podkast av RARECast - Torsdager

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

Kategorier:

Tim Guilliams, co-founder and CEO of Healx, discusses the origin of the company, its lead asset in development for neurofibromatosis type 1, and how he views the company’s progress to date.

Visit the podcast's native language site